You are here
New development in translational research in schizophrenia: towards therapy and prevention beyond dopamine antagonism
Interview with Prof. Kim Q. DO, recorded at ECNP Congress 2016, ViennaProf. Do describes the interaction of oxidative stress with neuroinflammation and glutamate/NDMA receptor hypofunction. A translational approach is taken, involving...
- Michael Davidson, Chaim Sheba Medical Center, Israel, discusses the race to find biomarkers and develop precise diagnostic tools to identify...
Olfactory identification deficits at identification as ultra-high risk for psychosis are associated with poor functional outcome
A. Lin, W.J. Brewer, A.R. Yung, B. Nelson, C. Pantelis, S.J. Wood
Schizophrenia Research, 2-3, 161, pages 156 - 162
“This month we focus on the need for more precise diagnostic tools in the early stage of illness – i.e....
The association between cognitive deficits and depressive symptoms in at-risk mental state: A comparison with first-episode psychosis
Noriyuki Ohmuro, Kazunori Matsumoto, Masahiro Katsura, Chika Obara, Tatsuo Kikuchi, Yumiko Hamaie, Atsushi Sakuma, Kunio Iizuka, Fumiaki Ito, Hiroo Matsuoka
Schizophrenia Research, 1-3, 162, pages 67 - 73